Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous Adipose Stem Cells for Facial Nerve Injury in Hemifacial Spasm
NCT02853942Phase 1Unknown
- Sponsor
- Xinhua Hospital
- Start
- Oct 2016
- Primary completion
- Oct 2017
- Modality
- Stem Cell Therapies
01
Overview
Phase 1, randomised, double-blind trial of autologous adipose-derived mesenchymal stromal cells in facial nerve injury (2 arms), sponsored by Xinhua Hospital. Primary endpoint: House-Brackmann facial nerve grading scale at 3 months. Status: unknown.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
facial nerve injury
Beyond the preview
Go deeper on NCT02853942.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02853942.